1001 related articles for article (PubMed ID: 19179053)
1. Inhibitory efficacy of various antibiotics on matrix and viable mass of Staphylococcus aureus and Pseudomonas aeruginosa biofilms.
Toté K; Berghe DV; Deschacht M; de Wit K; Maes L; Cos P
Int J Antimicrob Agents; 2009 Jun; 33(6):525-31. PubMed ID: 19179053
[TBL] [Abstract][Full Text] [Related]
2. Biofilm susceptibility to metal toxicity.
Harrison JJ; Ceri H; Stremick CA; Turner RJ
Environ Microbiol; 2004 Dec; 6(12):1220-7. PubMed ID: 15560820
[TBL] [Abstract][Full Text] [Related]
3. In vitro effectiveness of the antibiotic lock technique (ALT) for the treatment of catheter-related infections by Pseudomonas aeruginosa and Klebsiella pneumoniae.
Lee MY; Ko KS; Song JH; Peck KR
J Antimicrob Chemother; 2007 Oct; 60(4):782-7. PubMed ID: 17681978
[TBL] [Abstract][Full Text] [Related]
4. Bactericidal activity of various antibiotics against biofilm-producing Pseudomonas aeruginosa.
Abdi-Ali A; Mohammadi-Mehr M; Agha Alaei Y
Int J Antimicrob Agents; 2006 Mar; 27(3):196-200. PubMed ID: 16459057
[TBL] [Abstract][Full Text] [Related]
5. A model for testing drug susceptibility of Pseudomonas aeruginosa and Staphylococcus aureus grown in biofilms on medical devices.
Kétyi I
Acta Microbiol Immunol Hung; 1995; 42(2):215-9. PubMed ID: 7551716
[TBL] [Abstract][Full Text] [Related]
6. Maggot excretions/secretions are differentially effective against biofilms of Staphylococcus aureus and Pseudomonas aeruginosa.
van der Plas MJ; Jukema GN; Wai SW; Dogterom-Ballering HC; Lagendijk EL; van Gulpen C; van Dissel JT; Bloemberg GV; Nibbering PH
J Antimicrob Chemother; 2008 Jan; 61(1):117-22. PubMed ID: 17965032
[TBL] [Abstract][Full Text] [Related]
7. [Susceptibility of Staphylococcus aureus biofilms to vancomycin, gemtamicin and rifampin].
Kotulová D; Slobodníková L
Epidemiol Mikrobiol Imunol; 2010 Apr; 59(2):80-7. PubMed ID: 20586169
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of honey on Staphylococcus aureus and Pseudomonas aeruginosa biofilms.
Alandejani T; Marsan J; Ferris W; Slinger R; Chan F
Otolaryngol Head Neck Surg; 2009 Jul; 141(1):114-8. PubMed ID: 19559969
[TBL] [Abstract][Full Text] [Related]
9. Effect of antibiotic co-administration on young and mature biofilms of cystic fibrosis clinical isolates: the importance of the biofilm model.
Tré-Hardy M; Macé C; El Manssouri N; Vanderbist F; Traore H; Devleeschouwer MJ
Int J Antimicrob Agents; 2009 Jan; 33(1):40-5. PubMed ID: 18801647
[TBL] [Abstract][Full Text] [Related]
10. Combinations of maggot excretions/secretions and antibiotics are effective against Staphylococcus aureus biofilms and the bacteria derived therefrom.
van der Plas MJ; Dambrot C; Dogterom-Ballering HC; Kruithof S; van Dissel JT; Nibbering PH
J Antimicrob Chemother; 2010 May; 65(5):917-23. PubMed ID: 20189943
[TBL] [Abstract][Full Text] [Related]
11. Persister cells, the biofilm matrix and tolerance to metal cations in biofilm and planktonic Pseudomonas aeruginosa.
Harrison JJ; Turner RJ; Ceri H
Environ Microbiol; 2005 Jul; 7(7):981-94. PubMed ID: 15946294
[TBL] [Abstract][Full Text] [Related]
12. Effect of a solution containing citrate/Methylene Blue/parabens on Staphylococcus aureus bacteria and biofilm, and comparison with various heparin solutions.
Sauer K; Steczko J; Ash SR
J Antimicrob Chemother; 2009 May; 63(5):937-45. PubMed ID: 19282330
[TBL] [Abstract][Full Text] [Related]
13. In vitro production of biofilm in a flow cell system in a strain of Pseudomonas aeruginosa and Staphylococcus aureus and determination of efficiency of ciprofloxacin against them.
Gupta S; Agarwal S; Sahoo DR; Muralidharan S
Indian J Pathol Microbiol; 2011; 54(3):569-71. PubMed ID: 21934223
[TBL] [Abstract][Full Text] [Related]
14. Comparison of antibiotic susceptibility and plasmid content, between biofilm producing and non-producing clinical isolates of Pseudomonas aeruginosa.
Delissalde F; Amábile-Cuevas CF
Int J Antimicrob Agents; 2004 Oct; 24(4):405-8. PubMed ID: 15380270
[TBL] [Abstract][Full Text] [Related]
15. High in vitro antimicrobial activity of synthetic antimicrobial peptidomimetics against staphylococcal biofilms.
Flemming K; Klingenberg C; Cavanagh JP; Sletteng M; Stensen W; Svendsen JS; Flaegstad T
J Antimicrob Chemother; 2009 Jan; 63(1):136-45. PubMed ID: 19010828
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity of antibiotic combinations against Pseudomonas aeruginosa biofilm and planktonic cultures.
Tré-Hardy M; Vanderbist F; Traore H; Devleeschouwer MJ
Int J Antimicrob Agents; 2008 Apr; 31(4):329-36. PubMed ID: 18280117
[TBL] [Abstract][Full Text] [Related]
17. A new colorimetric microtitre model for the detection of Staphylococcus aureus biofilms.
Toté K; Vanden Berghe D; Maes L; Cos P
Lett Appl Microbiol; 2008 Feb; 46(2):249-54. PubMed ID: 18069978
[TBL] [Abstract][Full Text] [Related]
18. Melittin and its potential in the destruction and inhibition of the biofilm formation by Staphylococcus aureus, Escherichia coli and Pseudomonas aeruginosa isolated from bovine milk.
Picoli T; Peter CM; Zani JL; Waller SB; Lopes MG; Boesche KN; Vargas GDÁ; Hübner SO; Fischer G
Microb Pathog; 2017 Nov; 112():57-62. PubMed ID: 28943153
[TBL] [Abstract][Full Text] [Related]
19. In vitro activity of mupirocin on clinical isolates of Staphylococcus aureus and its potential implications in chronic rhinosinusitis.
Ha KR; Psaltis AJ; Butcher AR; Wormald PJ; Tan LW
Laryngoscope; 2008 Mar; 118(3):535-40. PubMed ID: 18090864
[TBL] [Abstract][Full Text] [Related]
20. Biofilm formation by Staphylococcus aureus and Pseudomonas aeruginosa is associated with an unfavorable evolution after surgery for chronic sinusitis and nasal polyposis.
Bendouah Z; Barbeau J; Hamad WA; Desrosiers M
Otolaryngol Head Neck Surg; 2006 Jun; 134(6):991-6. PubMed ID: 16730544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
